GVR Report cover India Malaria Diagnostics Market Size, Share & Trends Report

India Malaria Diagnostics Market Size, Share & Trends Analysis Report By Technology (RDTs, Microscopy, Molecular Diagnostic Tests), By End Use (Hospitals & Clinics, Diagnostic Laboratories), And Segment Forecasts, 2019 - 2026

  • Report ID: GVR-4-68038-015-6
  • Number of Pages: 72
  • Format: Electronic (PDF)
  • Historical Range: 2015 - 2017
  • Industry: Healthcare

Report Overview

The India malaria diagnostics market size to be valued at USD 27.5 million by 2026 and is expected to grow at a compound annual growth rate (CAGR) of 5.4% during the forecast period. In India, malaria is primarily caused by Plasmodium vivax and Plasmodium falciparum. P. vivax is mostly found in the plains whereas P. falciparum is predominantly found in peripheral and forest areas of India. Malaria affects all population groups in India and is typically susceptible to pregnant women and children. High disease incidence has been recorded in states such as Chhattisgarh, Odisha, Madhya Pradesh, and Maharashtra. These states witness perennial transmission of malaria owing to inadequate health infrastructure in the hilly and forest areas. Also, there is low awareness regarding the prevention and control of malaria among the various tribal population, facilitating an increase in disease prevalence.

India Malaria Diagnostics Market size, by technology

The rise in the incidence of malaria is one of the major factors expected to fuel market growth. According to the World Malaria Report published by WHO, 15 countries in Sub-Saharan Africa as well as India contributed to over 80% of the global malaria burden. India is the only exception wherein cases of urban malaria are observed to date. Similarly, almost 80% of malarial deaths were reported in 17 countries in the Sub-Saharan region and India. Therefore, the growing prevalence of malaria is expected to increase the demand for malaria diagnostic solutions during the forecast period.

Increasing demand for diagnostic tools in India is anticipated to propel market growth during the forecast period. Malaria during pregnancy can affect in more than one way, causing low birth weight, stillbirths, and congenital infection. According to the Centers for Disease Control and Prevention (CDC), pregnant women are three times more susceptible to malarial infections. Rapid diagnosis and subsequent treatment plans are thus vital in the management of malaria. As RDTs facilitate easy and rapid diagnosis, they have been used extensively in the management of malaria in India. Launch of novel diagnostic products such as Becton, Dickinson, and Co.’s SightDX platform facilitates rapid diagnosis and easy sample preparation. Thus, a rising number of malarial infections are generating the demand for easy and rapid diagnostic techniques for this disease.

Rise in technological advancements to provide efficient diagnosis is one of the major factors accelerating market growth. Increasing demand for high-quality and cost-efficient diagnostic methods are likely to trigger advancements in the industry. For instance, in 2016, Becton, Dickinson & Company announced the introduction of Parasight Malaria Detection Platform for hospitals and pathology labs in India. This platform is a computer vision platform that automatically analyzes the sample and also provides results in four minutes. This platform also uses innovative software algorithms, quicker sample preparation, and specialized optics. These advancements are likely to improve access to malaria diagnostics, especially in remote areas, wherein there is a lack of skilled professionals for testing.

Rising investments by government bodies, market players, and other private investors to curb disease prevalence is one of the major factors driving the market. According to data from WHO, in 2017, approximately USD 3.1 billion was invested in the elimination of malaria by private international investors and government authorities of malaria-endemic nations. Estimates from the same source also indicate that over USD 300 million was invested in the South East Asia region, wherein India carries the largest disease burden. Thus, an increase in initiatives by the government to reduce the incidence of malaria is anticipated to fuel market growth.

India Malaria Diagnostics Market Trends

The market is being driven by rising concerns over malaria infection and the introduction of novel diagnostic techniques. The surge in technological advancements related to diagnostic tools and an increasing number of malarial infections are boosting the demand for convenient and rapid diagnostic solutions for malaria, which is expected to drive market growth during the forecast period.

Investments by government bodies, market participants, and other private investors to reduce the illness severity are expected to provide opportunities for this market. Furthermore, the rise in government awareness programs and research for improved malaria diagnostics are among other factors driving the market expansion. However, in underdeveloped countries, a lack of understanding of healthcare solutions is expected to act as a challenge for the malaria diagnostics market.

Technology Insights

Based on technology, the India malaria diagnostics market is segmented into rapid diagnostic tests, microscopy, and molecular diagnostic tests. The molecular diagnostics segment is expected to witness the fastest growth owing to accurate diagnosis offered by these tests. Molecular diagnostic tests include real-time PCR or quantitative PCR (qPCR) and Polymerase Chain Reaction (PCR). The usage of real-time PCR using DNA extracted from the blood samples have been used for the detection of low parasite count. However, the market share of these tests is less due to the lack of skilled workforce and specialized laboratories in India.

The microscopy method is also expected to grow owing to the rise in the use of microscopy techniques for the diagnosis of the disease. This technique is one of the most reliable and traditional methods used for disease diagnosis. Malarial parasites such as P. malaria, P. vivax, P. falciparum, and P. ovale can be identified using this technique. Also, parasite density can be quantified to design treatment plans accordingly.

Rapid diagnostic tests are another method that is used for the detection of specific malaria antigens from the blood sample. This test makes use of a test card, wherein the blood sample is applied along with specific reagents. The appearance of specific bands in the test card, within 15 to 20 minutes, indicates the presence of infection with either of the human malarial parasites. These RDTs are capable of detecting P. falciparum, P. malariae, P. ovale, and P. vivax species of human malaria. Malarial RDTs are typically used where microscopy examination is not feasible, especially in remote areas with limited access to healthcare infrastructure and high-quality microscopy services.

End-use Insights

Based on end-use, the market is segmented into hospitals and clinics, diagnostic laboratories, blood banks, and academic and research institutes. The hospitals and clinics segment accounted for the largest market share in 2018 as the majority of the population relies on these long-term facilities for diagnosis, treatment, and management of diseases. In urban India, the easy availability of diagnostic devices, awareness, and experienced healthcare professionals facilitates the easy and effective treatment of malaria. In these areas, malaria is generally prevalent during and post monsoons between July and October. In urban areas, the disease outbreak is highly prevalent due to prolonged rainfall and climatic changes that facilitate the easy growth of Anopheles mosquitoes. Most of the urban regions in India seek treatment in privatized healthcare settings as they are well equipped with advanced diagnostic techniques and provide timely treatment. Thus, the hospitals and clinics segment is anticipated to witness significant growth during the forecast period.

India Malaria Diagnostics Market share, by end use

The blood bank segment is expected to witness steady growth during the forecast period. For infectious diseases such as malaria, influenza, and dengue, typically, blood donors are inquired regarding recent visits to endemic regions. In most cases, rapid diagnostic tests are used as primary screening tests, and serological tests are done post confirmatory results. Blood samples from the donor are analyzed and other disease illnesses are determined before blood transfusions. A rise in the number of surgical procedures has been reported in India, which can be attributed to the increase in the incidence of severe chronic diseases and accidents. This has created a significant demand for blood donations in the nation, facilitating increased demand for malarial diagnostic devices.

Key Companies & Market Share Insights

Rise in strategic collaborations by market players is expected to fuel the market growth during the forecast period. For instance, in February 2018, Siemens Healthineers India partnered with an Indian startup Jana Care to introduce a smartphone-based diagnostic platform called Aina. This diagnostic platform can be used in smartphones and it helps in reading paper strips of all kinds, enabling affordable and accurate testing in any healthcare setting. Some of the prominent players in the India malaria diagnostics market include:

  • Abbott Laboratories; Siemens Healthineers

  • Bio-Rad Laboratories

  • Beckman Coulter, Inc.

  • Access Bio, Inc.

  • Premier Medical Corporation Pvt. Ltd.

  • Olympus Corporation

  • Nikon Corporation

  • J. Mitra & Co. Pvt. Ltd.

  • Tulip Diagnostics Ltd.

  • Microgene Diagnostic Systems Pvt. Ltd.

India Malaria Diagnostics Market Report Scope

                  Report Attribute


The market size value in 2020

USD 20.02 million

The revenue forecast in 2026

USD 27.74 million

Growth Rate

CAGR of 5.4% from 2019 to 2026

The base year for estimation


Historical data

2015 - 2017

Forecast period

2019 - 2026

Quantitative units

Revenue in USD million and CAGR from 2019 to 2026

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Technology, end-use

Country scope


Key companies profiled

Abbott Laboratories; Siemens Healthineers; Bio-Rad Laboratories; Beckman Coulter, Inc.; Access Bio, Inc.; Premier Medical Corporation Pvt. Ltd.; Olympus Corporation; Nikon Corporation; J. Mitra & Co. Pvt. Ltd.; Tulip Diagnostics Ltd.; Microgene Diagnostic Systems Pvt. Ltd.

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

India Malaria Diagnostics Market Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2026. For this study, Grand View Research has segmented the India malaria diagnostics market report based on technology and end use:

India Malaria Diagnostics Market Segmentation

  • Technology Outlook (Revenue, USD Million, 2015 - 2026)

    • Microscopy

    • Rapid Diagnostic Tests (RDT)

    • Molecular Diagnostic Tests

      • Conventional PCR

      • Real-Time PCR (qPCR or quantitative PCR)

  • End-use Outlook (Revenue, USD Million, 2015 - 2026)

    • Hospitals & Clinics

    • Diagnostic Laboratories

    • Blood Banks

    • Academic and Research Institutes

Frequently Asked Questions About This Report

gvr icn


gvr icn

This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now

Certified Icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.